Michael Schrader: How AI Is Changing Biotech Startups Stories in Life Sciences

Artificial intelligence is reshaping how biotech companies are built, funded, and scaled. In this episode of Stories in Life Sciences by MedAxis AI, Christopher Wilson sits down with Michael Schrader, Co-founder and former CEO of Vaxess Technologies, to explore what that shift means for the next generation of founders.Michael's path from mechanical engineer to biotech entrepreneur spans mission-driven innovation, creative problem-solving, and the hard lessons of building a globally recognized vaccine delivery company. He brings a grounded perspective on what it actually takes to launch and grow a biotech startup in today's landscape.In this episode of Stories in Life Sciences, we cover:How AI is lowering barriers for new biotech founders in design, prototyping, and regulatory workLessons from building Vaxess Technologies, a globally recognized vaccine delivery companyThe role of mission and perseverance in biotech entrepreneurshipHow creative funding models and global thinking support biotech growthWhy collaboration and diversity drive better problem-solving in life sciencesWhat the next generation of AI-powered biotech startups looks likeWho this is for: founders, investors, and researchers in biotech, deep tech, AI in healthcare, and life sciences who want to understand how artificial intelligence is changing how companies are built.Guest: Michael SchraderCo-founder and Former CEO, Vaxess Technologies https://www.linkedin.com/in/michaelschraderHost:Christopher WilsonFound, MedAxis AIwww.medaxisai.orghttps://www.linkedin.com/in/christopher-wilson-medaxisai https://www.linkedin.com/company/medaxisaiFollow Stories in Life Sciences on Spotify, Apple Podcasts, and YouTube for new episodes.